In this issue:
Avacopan for the treatment of ANCA-associated vasculitis
Baricitinib plus remdesivir for hospitalized adults with Covid-19
Polypill with/without aspirin in persons without CV disease
IL-6 receptor inhibition in primary Sjögren syndrome
Efficacy and safety of abatacept in active primary Sjögren’s syndrome
Efficacy of tocilizumab in patients with hand OA
Upadacitinib for psoriatic arthritis refractory to biologics
Inhaled treprostinil in pulmonary hypertension
Revisiting the use of remission criteria for RA
JAK inhibition with baricitinib in refractory juvenile dermatomyositis
Please login below to download this issue (PDF)